Regulus Therapeutics
RGLS
#7201
Rank
C$0.80 B
Marketcap
C$11.70
Share price
0.00%
Change (1 day)
447.93%
Change (1 year)

Regulus Therapeutics (RGLS) - Net assets

Net assets on the balance sheet as of March 2025 : C$98.93 Million

According to Regulus Therapeutics's latest financial reports the company has C$98.93 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Regulus Therapeutics - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.10 B290.17%
2023-12-31$C$28.1 M-37.79%
2022-12-31$C$45.17 M-35.5%
2021-12-31$C$70.04 M111.06%
2020-12-31$C$33.18 M26.95%
2019-12-31$C$26.14 M-427.81%
2018-12-31$-C$7.98 Million-118.01%
2017-12-31$C$44.27 M-41.25%
2016-12-31$C$75.35 M-56.22%
2015-12-31$C$0.17 B12.35%
2014-12-31$C$0.15 B53.99%
2013-12-31$C$99.48 M61.12%
2012-12-31$C$61.74 M-246.29%
2011-12-31$-C$42.21 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sanofi
SNY
C$113.79 B 114,924.34%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$27.01 B 27,204.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$33.54 B 33,805.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$72.19 B 72,870.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$34.90 B 35,184.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-C$27.17 Million-127.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$5.16 B 5,120.85%๐Ÿ‡บ๐Ÿ‡ธ USA